FRANKFURT (Reuters) – Sanofi’s finance chief said on Wednesday that a decline in the French company’s share price in response to litigation threats and a cancer drug development setback was …
Shore News Network is a free website that does not use paywalls or charge for access to original, breaking news content. In order to provide this free service, we rely on advertisements. Please support our journalism by disabling your ad blocker for this website.